The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer

Benjamin T. Ristau, David Cahn, Robert G. Uzzo, Brian F. Chapin, Marc C. Smaldone

Research output: Contribution to journalReview article

11 Scopus citations


A lack of quality evidence comparing management strategies confounds complex treatment decisions for patients with high-risk prostate cancers. No randomized trial comparing surgery to radiation has been successfully completed. Despite inherent selection biases, however, observational and registry data suggest improved outcomes for patients initially managed with prostatectomy. As consensus shifts away from aggressive treatment for low-risk disease and toward multimodal treatment of locally advanced and metastatic disease, there is renewed interest in surgery for local control in patients presenting with high-risk localized, node-positive and minimally metastatic disease. The objective of this review is to examine the evidence evaluating clinical outcomes of patients with high-risk clinically localized, node-positive and metastatic prostate cancer treated with radical prostatectomy.

Original languageEnglish (US)
Pages (from-to)687-699
Number of pages13
JournalFuture Oncology
Issue number5
StatePublished - Mar 2016



  • cytoreductive surgery
  • outcomes
  • prostate cancer
  • radical prostatectomy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this